Healthcare Services Group (HCSG) Financials

$13.25 -0.39 (-2.86%)

Closing price 04:00 PM Eastern

Extended Trading

$13.26 +0.02 (+0.11%)

As of 04:11 PM Eastern

Annual Income Statements for Healthcare Services Group

This table shows Healthcare Services Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	22	58	77	88	84	65	99	47	27	40	39
Consolidated Net Income / (Loss)	22	58	77	88	84	65	99	49	34	38	39
Net Income / (Loss) Continuing Operations	22	58	77	88	84	65	99	49	34	38	39
Total Pre-Tax Income	32	90	120	133	100	85	129	66	45	53	53
Total Operating Income	30	89	118	124	98	78	117	57	53	48	45
Total Gross Profit	138	201	223	251	234	228	268	231	193	215	228
Total Revenue	1,293	1,437	1,563	1,861	2,003	1,841	1,760	1,642	1,690	1,671	1,716
Operating Revenue	1,293	1,437	1,563	1,861	2,003	1,841	1,760	1,642	1,690	1,671	1,716
Total Cost of Revenue	1,155	1,236	1,339	1,611	1,768	1,613	1,492	1,411	1,497	1,457	1,488
Operating Cost of Revenue	1,155	1,236	1,339	1,611	1,768	1,613	1,492	1,411	1,497	1,457	1,488
Total Operating Expenses	108	112	105	127	137	150	151	173	140	167	183
Selling, General & Admin Expense	108	112	105	127	137	150	151	173	140	167	183
Total Other Income / (Expense), net	1.63	0.71	2.63	9.08	2.07	7.22	12	8.05	-8.41	5.08	7.91
Interest & Investment Income	1.63	0.71	2.63	10	2.07	7.22	12	8.05	-8.41	5.08	7.91
Income Tax Expense	9.86	32	43	45	16	21	31	17	10	15	13
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-	-	-	1.56	7.48	-1.63	0.47
Basic Earnings per Share	$0.31	$0.81	$1.06	$1.20	$1.13	$0.87	$1.32	$0.65	$0.46	$0.52	$0.54
Weighted Average Basic Shares Outstanding	70.62M	71.83M	72.75M	73.36M	74.00M	74.36M	74.70M	74.82M	74.34M	74.29M	73.75M
Diluted Earnings per Share	$0.31	$0.80	$1.05	$1.19	$1.12	$0.87	$1.32	$0.65	$0.46	$0.52	$0.53
Weighted Average Diluted Shares Outstanding	71.34M	72.51M	73.47M	74.35M	74.61M	74.59M	74.79M	74.96M	74.35M	74.34M	73.99M
Weighted Average Basic & Diluted Shares Outstanding	70.50M	71.60M	73M	73.50M	73.90M	74.40M	74.72M	74.00M	74.39M	73.58M	73.49M

This table shows Healthcare Services Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	11	13	7.39	-6.69	26	15	-2.23	16	10	18	-32
Consolidated Net Income / (Loss)	16	12	8.25	-5.05	24	15	-1.79	14	12	17	-32
Net Income / (Loss) Continuing Operations	16	12	8.25	-5.05	24	15	-1.79	14	12	17	-32
Total Pre-Tax Income	20	16	11	-6.33	32	21	-1.99	19	15	24	-42
Total Operating Income	17	15	9.30	-4.60	28	18	-2.89	17	14	23	-46
Total Gross Profit	57	55	51	34	75	65	42	63	59	68	2.96
Total Revenue	424	417	419	411	424	423	426	428	438	448	458
Operating Revenue	424	417	419	411	424	423	426	428	438	448	458
Total Cost of Revenue	367	362	368	377	349	359	385	365	379	380	456
Operating Cost of Revenue	367	362	368	377	349	359	385	365	379	380	456
Total Operating Expenses	40	40	41	39	46	47	44	47	45	45	49
Selling, General & Admin Expense	40	40	41	39	46	47	44	47	45	45	49
Total Other Income / (Expense), net	2.37	1.35	1.64	-1.74	3.83	3.70	0.91	2.28	1.03	0.89	4.32
Interest & Investment Income	2.37	1.35	1.64	-1.74	3.83	3.70	0.91	2.28	1.03	0.89	4.32
Income Tax Expense	3.76	4.48	2.68	-1.29	8.79	6.01	-0.20	4.78	2.89	6.67	-9.52
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-1.21	0.86	1.65	-2.93	0.33	0.45	-2.09	1.79	-0.50	-0.37
Basic Earnings per Share	$0.22	$0.16	$0.11	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.16	$0.23	($0.44)
Weighted Average Basic Shares Outstanding	74.34M	74.50M	74.48M	74.36M	74.29M	73.93M	73.85M	73.69M	73.75M	73.67M	73.16M
Diluted Earnings per Share	$0.22	$0.16	$0.11	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.15	$0.23	($0.44)
Weighted Average Diluted Shares Outstanding	74.35M	74.52M	74.57M	74.36M	74.34M	74.06M	73.85M	73.93M	73.99M	73.96M	73.16M
Weighted Average Basic & Diluted Shares Outstanding	74.39M	74.20M	74.20M	73.85M	73.58M	73.65M	73.38M	73.29M	73.49M	72.92M	72.41M

This table details how cash moves in and out of Healthcare Services Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	11	-42	-9.34	-14	16	1.30	112	-69	-45	28	5.80
Net Cash From Operating Activities	58	63	41	7.63	80	94	217	37	-8.17	43	31
Net Cash From Continuing Operating Activities	58	63	41	7.63	80	94	217	37	-8.17	43	31
Net Income / (Loss) Continuing Operations	22	58	77	88	84	65	99	49	34	38	39
Consolidated Net Income / (Loss)	22	58	77	88	84	65	99	49	34	38	39
Depreciation Expense	7.27	7.66	7.50	8.89	9.27	14	14	15	15	14	15
Amortization Expense	0.35	0.68	1.72	1.30	1.37	1.43	1.82	2.28	2.22	2.14	1.50
Non-Cash Adjustments To Reconcile Net Income	3.71	6.03	5.90	12	59	25	9.45	14	52	39	49
Changes in Operating Assets and Liabilities, net	25	-9.03	-51	-103	-73	-11	93	-43	-112	-50	-74
Net Cash From Investing Activities	-6.46	-62	-6.45	-15	-9.59	-16	-37	-23	2.58	-3.29	6.05
Net Cash From Continuing Investing Activities	-6.46	-62	-6.45	-15	-9.59	-16	-37	-23	2.58	-3.29	6.05
Purchase of Property, Plant & Equipment	-5.80	-5.00	-5.44	-5.40	-4.94	-4.37	-4.34	-5.69	-5.21	-5.41	-6.34
Acquisitions	-	0.00	0.00	-4.58	-	0.00	0.00	-24	-0.11	0.00	-2.75
Purchase of Investments	-5.14	-75	-29	-34	-14	-34	-39	-20	-2.88	0.00	-52
Sale of Property, Plant & Equipment	0.08	0.27	0.28	0.34	0.64	0.20	0.27	0.21	0.39	0.12	0.21
Sale and/or Maturity of Investments	4.39	18	28	29	9.01	21	6.27	27	10	1.99	67
Net Cash From Financing Activities	-40	-43	-44	-6.96	-54	-76	-68	-83	-39	-12	-31
Net Cash From Continuing Financing Activities	-40	-43	-44	-6.96	-54	-76	-68	-83	-39	-12	-31
Repayment of Debt	-	-	0.00	-	-5.38	-20	-10	0.00	25	0.00	-25
Repurchase of Common Equity	-	-	-	-	-0.28	-0.59	-0.68	-23	-1.07	-12	-6.05
Payment of Dividends	-49	-51	-53	-55	-57	-59	-61	-62	-63	0.00	0.00
Issuance of Common Equity	0.11	0.11	0.11	0.10	0.09	0.09	0.09	0.09	0.11	0.00	0.00
Other Financing Activities, net	8.82	8.12	8.95	13	8.80	3.63	2.92	2.43	0.41	0.00	0.00
Cash Interest Paid	0.16	0.26	0.57	1.36	3.09	3.46	1.37	1.39	2.82	7.81	6.49
Cash Income Taxes Paid	25	7.90	33	35	38	20	45	21	3.31	5.59	15

This table details how cash moves in and out of Healthcare Services Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Net Change in Cash & Equivalents	6.65	-10	13	2.65	23	-0.35	-24	-1.41	32	4.25	19
Net Cash From Operating Activities	23	-16	7.40	2.94	49	-26	16	4.31	36	28	29
Net Cash From Continuing Operating Activities	23	-16	7.40	2.94	49	-26	16	4.31	36	28	29
Net Income / (Loss) Continuing Operations	16	12	8.25	-5.05	24	15	-1.79	14	12	17	-32
Consolidated Net Income / (Loss)	16	12	8.25	-5.05	24	15	-1.79	14	12	17	-32
Depreciation Expense	3.76	3.72	3.60	3.25	3.78	3.53	3.68	3.77	3.60	3.88	5.00
Amortization Expense	0.55	0.53	0.54	0.54	0.54	0.46	0.34	0.21	0.50	0.12	0.12
Non-Cash Adjustments To Reconcile Net Income	8.86	7.59	12	18	1.70	3.48	33	0.31	12	6.34	68
Changes in Operating Assets and Liabilities, net	-6.04	-40	-17	-14	20	-49	-19	-14	7.81	-0.07	-12
Net Cash From Investing Activities	-0.29	-0.74	0.11	-1.27	-1.38	12	-28	0.29	22	-14	-2.35
Net Cash From Continuing Investing Activities	-0.29	-0.74	0.11	-1.27	-1.38	12	-28	0.29	22	-14	-2.35
Purchase of Property, Plant & Equipment	-1.07	-1.01	-1.09	-1.88	-1.43	-2.20	-1.31	-1.40	-1.43	-1.74	-1.36
Purchase of Investments	-	-	-	-	-	0.00	-	-14	-0.60	-3.44	-1.18
Sale of Property, Plant & Equipment	0.21	0.06	0.03	0.04	-	0.03	0.13	0.04	0.02	0.03	0.05
Sale and/or Maturity of Investments	0.57	0.21	1.17	0.57	0.05	17	11	15	24	0.10	0.13
Net Cash From Financing Activities	-16	6.91	5.00	0.98	-25	14	-13	-6.01	-26	-8.78	-7.68
Net Cash From Continuing Financing Activities	-16	6.91	5.00	0.98	-25	14	-13	-6.01	-26	-8.78	-7.68
Repurchase of Common Equity	-	-3.09	-	-4.02	-5.05	-1.03	-3.00	-1.01	-1.01	-8.78	-7.68

This table presents Healthcare Services Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	470	481	528	676	693	723	785	778	721	791	803
Total Current Assets	335	365	415	527	508	516	572	546	509	572	557
Cash & Equivalents	75	33	24	9.56	26	27	139	71	26	54	57
Restricted Cash	-	-	-	-	-	-	-	-	-	0.00	28
Short-Term Investments	12	69	68	73	76	91	125	114	95	93	51
Note & Lease Receivable	198	215	271	379	342	341	255	293	337	39	51
Accounts Receivable	-	-	-	-	-	-	-	-	-	345	331
Inventories, net	35	36	38	42	41	37	32	26	21	18	17
Prepaid Expenses	9.79	11	14	24	22	20	21	33	23	22	22
Plant, Property, & Equipment, net	13	13	13	14	13	0.00	0.00	28	23	29	28
Total Noncurrent Assets	122	103	100	135	172	207	213	203	189	190	218
Noncurrent Note & Lease Receivables	5.18	2.97	7.53	15	43	47	34	29	33	25	41
Goodwill	44	44	44	51	51	51	51	75	76	76	76
Intangible Assets	20	17	14	31	27	22	18	21	16	12	9.44
Noncurrent Deferred & Refundable Income Taxes	27	13	9.82	7.50	21	20	36	32	31	35	38
Employee Benefit Assets	25	25	24	29	29	37	47	47	33	41	50
Other Noncurrent Operating Assets	0.04	0.05	0.05	1.26	1.26	29	27	0.00	0.81	1.66	4.09
Total Liabilities & Shareholders' Equity	470	481	528	676	693	723	785	778	721	791	803
Total Liabilities	194	184	190	276	252	262	305	325	303	334	303
Total Current Liabilities	118	96	101	184	163	149	162	191	189	217	193
Accounts Payable	44	41	43	74	61	54	52	64	68	83	81
Accrued Expenses	8.96	14	4.40	4.56	8.89	16	18	27	18	21	25
Current Deferred & Payable Income Tax Liabilities	0.00	3.21	7.69	15	7.14	8.08	-	-	0.00	7.20	8.39
Current Employee Benefit Liabilities	65	38	46	54	35	36	71	76	55	58	53
Other Current Liabilities	-	-	0.00	35	51	33	22	24	23	23	25
Total Noncurrent Liabilities	76	88	89	92	88	114	142	134	114	117	110
Capital Lease Obligations	-	-	-	-	-	-	11	11	8.10	11	8.03
Noncurrent Employee Benefit Liabilities	76	88	89	92	30	102	131	112	99	103	102
Other Noncurrent Operating Liabilities	-	-	-	-	-	12	0.00	10	6.14	2.99	0.39
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	276	296	339	400	441	460	480	453	418	457	500
Total Preferred & Common Equity	276	296	339	400	441	460	480	453	418	457	500
Total Common Equity	276	296	339	400	441	460	480	453	418	457	500
Common Stock	187	200	218	245	260	271	283	295	303	311	319
Retained Earnings	100	107	131	164	190	195	201	184	147	185	225
Treasury Stock	-11	-11	-10	-9.86	-9.66	-9.44	-8.96	-30	-28	-38	-41
Accumulated Other Comprehensive Income / (Loss)	0.03	0.54	-0.32	0.84	0.16	2.92	5.56	4.00	-3.48	-1.84	-2.32

This table presents Healthcare Services Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025
Period end date	6/30/2022	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025
Total Assets	740	722	719	762	751	804	800	806	823	802
Total Current Assets	522	513	510	549	533	580	573	578	575	532
Cash & Equivalents	32	20	16	29	31	29	26	27	64	83
Restricted Cash	-	-	-	-	-	25	25	26	29	30
Short-Term Investments	97	94	96	93	90	76	79	77	50	52
Note & Lease Receivable	332	347	351	380	368	407	399	406	49	32
Accounts Receivable	-	-	-	-	-	-	-	-	338	292
Inventories, net	24	23	20	20	19	18	18	17	17	17
Prepaid Expenses	34	24	25	26	24	26	26	25	27	27
Plant, Property, & Equipment, net	26	24	23	27	29	29	30	28	29	28
Total Noncurrent Assets	193	185	186	186	188	194	197	199	219	242
Noncurrent Note & Lease Receivables	33	27	32	31	29	23	21	23	36	45
Goodwill	76	76	76	76	76	76	76	76	80	80
Intangible Assets	18	17	15	14	13	11	11	10	10	8.26
Noncurrent Deferred & Refundable Income Taxes	33	34	28	28	33	35	39	36	40	53
Employee Benefit Assets	32	32	34	37	36	44	46	49	47	52
Other Noncurrent Operating Assets	-	-	0.76	0.71	1.81	4.30	4.51	5.61	6.09	3.64
Total Liabilities & Shareholders' Equity	740	722	719	762	751	804	800	806	823	802
Total Liabilities	302	300	279	311	309	329	328	317	309	325
Total Current Liabilities	184	182	162	190	188	209	209	197	199	214
Accounts Payable	66	67	64	66	71	73	72	77	79	78
Accrued Expenses	15	16	17	17	20	22	23	26	37	42
Current Deferred & Payable Income Tax Liabilities	-	-	-	1.36	1.27	12	4.28	4.50	9.60	1.39
Current Employee Benefit Liabilities	66	47	22	41	26	40	58	44	48	68
Other Current Liabilities	26	26	24	25	25	23	22	22	26	25
Total Noncurrent Liabilities	118	118	116	122	121	120	119	120	110	111
Capital Lease Obligations	9.86	8.75	8.59	12	12	11	11	9.03	7.95	7.05
Noncurrent Employee Benefit Liabilities	102	102	101	106	106	107	107	110	100	103
Other Noncurrent Operating Liabilities	6.41	8.00	6.45	3.85	3.12	2.27	0.72	0.43	2.04	1.65
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	438	422	441	451	442	475	471	489	514	477
Total Preferred & Common Equity	438	422	441	451	442	475	471	489	514	477
Total Common Equity	438	422	441	451	442	475	471	489	514	477
Common Stock	299	301	304	307	309	313	315	317	321	324
Retained Earnings	170	155	167	176	170	200	199	213	242	209
Treasury Stock	-28	-28	-29	-29	-33	-36	-39	-40	-47	-55
Accumulated Other Comprehensive Income / (Loss)	-3.21	-5.51	-2.27	-3.13	-4.78	-2.17	-2.62	-0.52	-1.81	-1.44

This table displays calculated financial ratios and metrics derived from Healthcare Services Group's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.46%	11.11%	8.76%	19.10%	7.60%	-8.08%	-4.37%	-6.72%	2.94%	-1.11%	2.65%
EBITDA Growth	-45.77%	158.32%	30.37%	5.59%	-19.08%	-14.04%	42.94%	-44.19%	-5.24%	-8.57%	-5.19%
EBIT Growth	-52.09%	196.05%	32.23%	5.21%	-21.03%	-20.40%	50.50%	-50.98%	-7.82%	-9.43%	-6.14%
NOPAT Growth	-53.43%	177.71%	31.51%	8.58%	-0.50%	-27.74%	51.48%	-52.45%	-4.38%	-14.74%	-3.27%
Net Income Growth	-53.64%	165.56%	33.39%	13.99%	-5.33%	-22.68%	52.80%	-50.81%	-29.46%	12.10%	2.83%
EPS Growth	-53.73%	158.06%	31.25%	13.33%	-5.88%	-22.32%	51.72%	-50.76%	-29.23%	13.04%	1.92%
Operating Cash Flow Growth	79.52%	9.75%	-34.66%	-81.57%	948.90%	16.93%	132.11%	-82.92%	-122.01%	632.61%	-29.19%
Free Cash Flow Firm Growth	261.32%	26.55%	-57.72%	-44.70%	393.03%	-8.81%	269.92%	-104.27%	-19.16%	284.75%	-64.75%
Invested Capital Growth	-9.92%	2.66%	27.60%	28.28%	6.69%	1.14%	-33.54%	22.55%	18.33%	4.70%	7.76%
Revenue Q/Q Growth	3.01%	1.73%	2.12%	5.43%	0.02%	-2.54%	-1.33%	-0.17%	0.21%	-0.01%	0.82%
EBITDA Q/Q Growth	75.02%	-9.66%	18.93%	0.04%	8.16%	-12.93%	4.37%	-25.96%	26.12%	21.31%	-19.60%
EBIT Q/Q Growth	112.25%	-10.74%	20.49%	-0.26%	9.49%	-16.32%	5.03%	-31.48%	37.84%	30.85%	-24.60%
NOPAT Q/Q Growth	104.86%	-10.64%	18.80%	-3.50%	26.31%	-22.52%	7.35%	-32.55%	38.49%	24.43%	-22.45%
Net Income Q/Q Growth	84.70%	-9.85%	16.86%	-0.13%	15.75%	-16.39%	9.85%	-32.11%	47.24%	25.24%	-22.70%
EPS Q/Q Growth	93.75%	-11.11%	16.67%	1.71%	14.29%	-15.53%	9.09%	-32.29%	53.33%	23.81%	-24.29%
Operating Cash Flow Q/Q Growth	20.43%	-26.82%	-15.08%	15.19%	1.28%	9.14%	40.22%	-54.41%	-2,676.34%	156.69%	-30.06%
Free Cash Flow Firm Q/Q Growth	26.81%	-29.94%	-28.62%	442.35%	37.23%	-6.88%	29.62%	-114.43%	72.63%	385.83%	-75.43%
Invested Capital Q/Q Growth	-7.53%	0.11%	9.33%	2.62%	2.64%	-1.27%	-16.50%	1.36%	-3.66%	-8.40%	-5.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	10.66%	13.97%	14.28%	13.47%	11.71%	12.38%	15.22%	14.04%	11.44%	12.85%	13.29%
EBITDA Margin	2.92%	6.78%	8.13%	7.20%	5.42%	5.07%	7.57%	4.53%	4.17%	3.86%	3.56%
Operating Margin	2.33%	6.20%	7.54%	6.66%	4.89%	4.23%	6.66%	3.50%	3.13%	2.87%	2.62%
EBIT Margin	2.33%	6.20%	7.54%	6.66%	4.89%	4.23%	6.66%	3.50%	3.13%	2.87%	2.62%
Profit (Net Income) Margin	1.69%	4.04%	4.95%	4.74%	4.17%	3.51%	5.61%	2.96%	2.03%	2.30%	2.30%
Tax Burden Percent	68.91%	64.64%	64.29%	66.35%	83.60%	75.89%	76.39%	74.10%	76.86%	72.35%	74.56%
Interest Burden Percent	105.41%	100.80%	102.24%	107.33%	102.12%	109.27%	110.22%	114.02%	84.11%	110.59%	117.57%
Effective Tax Rate	31.09%	35.36%	35.71%	33.65%	16.40%	24.11%	23.61%	25.90%	23.14%	27.65%	25.44%
Return on Invested Capital (ROIC)	10.41%	30.10%	34.33%	29.13%	24.95%	17.37%	31.43%	16.82%	13.38%	10.28%	9.36%
ROIC Less NNEP Spread (ROIC-NNEP)	9.03%	29.61%	32.59%	22.22%	23.08%	12.40%	26.50%	14.02%	18.31%	6.60%	4.42%
Return on Net Nonoperating Assets (RNNOA)	-2.62%	-9.82%	-9.96%	-5.24%	-5.08%	-3.03%	-10.45%	-6.42%	-5.51%	-1.50%	-1.10%
Return on Equity (ROE)	7.79%	20.28%	24.37%	23.88%	19.87%	14.33%	20.98%	10.40%	7.86%	8.78%	8.25%
Cash Return on Invested Capital (CROIC)	20.85%	27.47%	10.07%	4.35%	18.48%	16.23%	71.72%	-3.45%	-3.42%	5.69%	1.89%
Operating Return on Assets (OROA)	6.72%	18.74%	23.33%	20.57%	14.30%	11.01%	15.55%	7.35%	7.07%	6.35%	5.65%
Return on Assets (ROA)	4.88%	12.21%	15.34%	14.65%	12.21%	9.13%	13.09%	6.21%	4.57%	5.08%	4.95%
Return on Common Equity (ROCE)	7.79%	20.28%	24.37%	23.88%	19.87%	14.33%	20.98%	10.40%	7.86%	8.78%	8.25%
Return on Equity Simple (ROE_SIMPLE)	7.92%	19.57%	22.84%	22.06%	18.95%	14.03%	20.54%	10.72%	8.19%	8.41%	7.90%
Net Operating Profit after Tax (NOPAT)	21	58	76	82	82	59	90	43	41	35	34
NOPAT Margin	1.60%	4.01%	4.84%	4.42%	4.08%	3.21%	5.09%	2.59%	2.41%	2.08%	1.96%
Net Nonoperating Expense Percent (NNEP)	1.38%	0.49%	1.74%	6.91%	1.87%	4.97%	4.93%	2.80%	-4.93%	3.68%	4.94%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	9.02%	7.04%	6.61%
Cost of Revenue to Revenue	89.34%	86.03%	85.72%	86.53%	88.29%	87.62%	84.78%	85.96%	88.56%	87.15%	86.71%
SG&A Expenses to Revenue	8.34%	7.77%	6.75%	6.81%	6.82%	8.15%	8.57%	10.54%	8.30%	9.98%	10.67%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.34%	7.77%	6.75%	6.81%	6.82%	8.15%	8.57%	10.54%	8.30%	9.98%	10.67%
Earnings before Interest and Taxes (EBIT)	30	89	118	124	98	78	117	57	53	48	45
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	38	97	127	134	108	93	133	74	71	64	61
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.32	6.90	6.97	8.16	5.78	3.46	3.98	2.77	2.13	1.68	1.70
Price to Tangible Book Value (P/TBV)	8.26	8.70	8.44	10.26	7.02	4.12	4.65	3.51	2.72	2.08	2.05
Price to Revenue (P/Rev)	1.35	1.42	1.51	1.75	1.27	0.87	1.09	0.76	0.53	0.46	0.50
Price to Earnings (P/E)	79.80	35.24	30.53	36.97	30.53	24.68	19.39	26.69	33.22	19.14	21.83
Dividend Yield	2.81%	2.51%	2.25%	1.69%	2.24%	3.69%	3.16%	4.95%	7.11%	0.00%	0.00%
Earnings Yield	1.25%	2.84%	3.28%	2.70%	3.28%	4.05%	5.16%	3.75%	3.01%	5.23%	4.58%
Enterprise Value to Invested Capital (EV/IC)	8.78	10.02	9.19	10.02	7.23	4.31	7.30	3.87	2.43	1.90	1.94
Enterprise Value to Revenue (EV/Rev)	1.28	1.35	1.45	1.71	1.22	0.80	0.94	0.66	0.47	0.39	0.42
Enterprise Value to EBITDA (EV/EBITDA)	43.94	19.94	17.89	23.72	22.56	15.83	12.45	14.51	11.36	10.15	11.84
Enterprise Value to EBIT (EV/EBIT)	55.08	21.81	19.29	25.66	25.02	18.95	14.16	18.79	15.12	13.64	16.07
Enterprise Value to NOPAT (EV/NOPAT)	79.92	33.74	30.00	38.68	29.92	24.97	18.54	25.36	19.67	18.86	21.55
Enterprise Value to Operating Cash Flow (EV/OCF)	28.70	30.65	54.86	416.70	30.58	15.77	7.64	29.10	0.00	15.05	23.49
Enterprise Value to Free Cash Flow (EV/FCFF)	39.90	36.96	102.24	258.79	40.41	26.72	8.12	0.00	0.00	34.06	106.81
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.03	0.08	0.08	0.02
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.03	0.02	0.02	0.02
Financial Leverage	-0.29	-0.33	-0.31	-0.24	-0.22	-0.24	-0.39	-0.46	-0.30	-0.23	-0.25
Leverage Ratio	1.60	1.66	1.59	1.63	1.63	1.57	1.60	1.67	1.72	1.73	1.67
Compound Leverage Factor	1.68	1.67	1.62	1.75	1.66	1.72	1.77	1.91	1.45	1.91	1.96
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.31%	2.44%	7.33%	7.35%	1.58%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.54%	5.07%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.31%	2.44%	1.79%	2.28%	1.58%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	97.69%	97.56%	92.67%	92.65%	98.42%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.15	0.47	0.56	0.13
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-1.90	-2.34	-1.25	-1.73	-2.09
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.15	0.11	0.17	0.13
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.13	0.27	0.81	1.04	0.24
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-2.83	-4.08	-2.17	-3.20	-3.80
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.13	0.27	0.20	0.32	0.24
Altman Z-Score	9.22	11.23	12.23	11.40	10.41	7.54	7.49	5.55	5.17	4.56	4.94
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.84	3.80	4.11	2.86	3.11	3.47	3.53	2.86	2.69	2.64	2.89
Quick Ratio	2.42	3.31	3.60	2.51	2.72	3.09	3.20	2.50	2.42	2.45	2.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	42	53	22	12	61	55	204	-8.73	-10	19	6.77
Operating Cash Flow to CapEx	1,010.68%	1,339.27%	801.24%	150.82%	1,861.19%	2,244.69%	5,340.87%	677.65%	-169.55%	823.05%	502.89%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	9.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	5.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	1.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.89	3.02	3.10	3.09	2.93	2.60	2.34	2.10	2.26	2.21	2.15
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.08
Inventory Turnover	34.02	34.45	36.15	40.17	42.18	41.38	43.83	49.01	63.45	73.49	84.46
Fixed Asset Turnover	107.43	111.13	117.75	138.05	151.66	0.00	0.00	0.00	66.18	64.60	60.23
Accounts Payable Turnover	26.49	29.08	31.75	27.44	26.02	27.84	27.98	24.20	22.56	19.23	18.10
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	71.88
Days Inventory Outstanding (DIO)	10.73	10.60	10.10	9.09	8.65	8.82	8.33	7.45	5.75	4.97	4.32
Days Payable Outstanding (DPO)	13.78	12.55	11.50	13.30	14.03	13.11	13.04	15.08	16.18	18.98	20.17
Cash Conversion Cycle (CCC)	-3.05	-1.96	-1.40	-4.21	-5.38	-4.29	-4.71	-7.64	-10.43	-14.02	56.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	189	194	247	317	338	342	227	279	330	345	372
Invested Capital Turnover	6.49	7.51	7.09	6.60	6.11	5.41	6.18	6.49	5.55	4.95	4.78
Increase / (Decrease) in Invested Capital	-21	5.02	53	70	21	3.87	-115	51	51	15	27
Enterprise Value (EV)	1,657	1,942	2,271	3,179	2,447	1,476	1,660	1,080	801	655	724
Market Capitalization	1,744	2,045	2,363	3,262	2,550	1,594	1,913	1,254	889	766	851
Book Value per Share	$3.90	$4.12	$4.67	$5.46	$5.97	$6.21	$6.46	$6.07	$5.65	$6.18	$6.82
Tangible Book Value per Share	$2.99	$3.26	$3.86	$4.34	$4.92	$5.22	$5.53	$4.79	$4.41	$5.00	$5.66
Total Capital	276	296	339	400	441	460	492	464	451	493	508
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	11	11	33	36	8.03
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	11	11	8.10	11	8.03
Net Debt	-87	-103	-92	-83	-102	-118	-253	-174	-88	-111	-128
Capital Expenditures (CapEx)	5.71	4.73	5.17	5.06	4.30	4.17	4.07	5.48	4.82	5.29	6.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	130	167	222	260	242	249	146	170	223	232	228
Debt-free Net Working Capital (DFNWC)	217	269	314	343	345	367	410	355	345	380	364
Net Working Capital (NWC)	217	269	314	343	345	367	410	355	320	355	364
Net Nonoperating Expense (NNE)	-1.12	-0.46	-1.69	-6.03	-1.73	-5.48	-9.15	-5.97	6.47	-3.68	-5.90
Net Nonoperating Obligations (NNO)	-87	-103	-92	-83	-102	-118	-253	-174	-88	-111	-128
Total Depreciation and Amortization (D&A)	7.62	8.34	9.22	10	11	15	16	17	18	16	16
Debt-free, Cash-free Net Working Capital to Revenue	10.04%	11.59%	14.22%	14.00%	12.10%	13.53%	8.28%	10.36%	13.20%	13.90%	13.31%
Debt-free Net Working Capital to Revenue	16.77%	18.74%	20.08%	18.44%	17.21%	19.94%	23.30%	21.64%	20.39%	22.72%	21.22%
Net Working Capital to Revenue	16.77%	18.74%	20.08%	18.44%	17.21%	19.94%	23.30%	21.64%	18.91%	21.23%	21.22%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.31	$0.81	$1.06	$1.20	$1.13	$0.87	$1.32	$0.61	$0.47	$0.52	$0.54
Adjusted Weighted Average Basic Shares Outstanding	70.62M	71.83M	72.75M	73.36M	74.00M	74.36M	74.70M	74.82M	74.34M	74.29M	73.75M
Adjusted Diluted Earnings per Share	$0.31	$0.80	$1.05	$1.19	$1.12	$0.87	$1.32	$0.61	$0.47	$0.52	$0.53
Adjusted Weighted Average Diluted Shares Outstanding	71.34M	72.51M	73.47M	74.35M	74.61M	74.59M	74.79M	74.96M	74.35M	74.34M	73.99M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	71.26M	72.18M	72.81M	73.68M	74.04M	74.40M	74.72M	74.00M	74.39M	73.58M	73.49M
Normalized Net Operating Profit after Tax (NOPAT)	21	58	76	82	82	59	90	43	41	35	34
Normalized NOPAT Margin	1.60%	4.01%	4.84%	4.42%	4.08%	3.21%	5.09%	2.59%	2.41%	2.08%	1.96%
Pre Tax Income Margin	2.45%	6.25%	7.70%	7.14%	4.99%	4.62%	7.34%	3.99%	2.64%	3.17%	3.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	90.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	60.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	87.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	56.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	224.61%	88.54%	68.92%	62.62%	68.48%	91.28%	61.52%	128.19%	185.07%	0.00%	0.00%
Augmented Payout Ratio	224.61%	88.54%	68.92%	62.62%	68.82%	92.19%	62.20%	175.45%	188.20%	31.66%	15.32%

This table displays calculated financial ratios and metrics derived from Healthcare Services Group's official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.85%	-2.24%	-1.39%	-0.75%	-0.04%	1.49%	1.76%	4.07%	3.30%	5.72%	7.55%
EBITDA Growth	212.95%	-15.38%	-34.11%	-113.19%	52.76%	13.35%	-91.63%	2,635.48%	-45.45%	24.99%	-3,755.34%
EBIT Growth	555.85%	-16.89%	-42.63%	-356.56%	65.92%	18.96%	-131.09%	459.76%	-51.60%	30.63%	-1,498.24%
NOPAT Growth	495.10%	-16.37%	-47.61%	-653.84%	49.52%	18.27%	-128.83%	483.38%	-46.45%	31.13%	-1,498.24%
Net Income Growth	229.61%	3.02%	21.03%	-1,667.39%	49.05%	31.17%	-121.66%	377.99%	-49.29%	12.54%	-1,710.18%
EPS Growth	266.67%	6.67%	22.22%	0.00%	45.45%	31.25%	-118.18%	371.43%	-53.13%	9.52%	-2,100.00%
Operating Cash Flow Growth	-27.04%	46.03%	-17.91%	129.71%	115.98%	-59.81%	120.44%	46.67%	-26.78%	205.64%	76.40%
Free Cash Flow Firm Growth	23.93%	51.66%	42.08%	43.38%	114.03%	68.10%	93.06%	91.05%	-400.56%	411.36%	1,035.29%
Invested Capital Growth	18.33%	13.71%	15.76%	10.11%	4.70%	6.33%	0.28%	4.17%	7.76%	-4.39%	-16.09%
Revenue Q/Q Growth	2.30%	-1.60%	0.41%	-1.80%	3.03%	-0.10%	0.67%	0.44%	2.26%	2.25%	2.42%
EBITDA Q/Q Growth	249.84%	-11.19%	-29.51%	-106.02%	4,152.04%	-35.32%	-94.80%	1,724.91%	-12.82%	50.99%	-252.17%
EBIT Q/Q Growth	857.96%	-13.71%	-37.19%	-149.42%	719.52%	-39.45%	-116.42%	671.81%	-16.65%	66.96%	-300.85%
NOPAT Q/Q Growth	2,285.87%	-22.82%	-34.37%	-145.83%	744.13%	-40.24%	-116.00%	709.35%	-10.04%	49.51%	-294.99%
Net Income Q/Q Growth	4,798.14%	-26.00%	-29.28%	-161.15%	565.78%	-36.09%	-111.68%	884.68%	-15.04%	44.53%	-287.87%
EPS Q/Q Growth	0.00%	-27.27%	-31.25%	-163.64%	557.14%	-34.38%	-109.52%	1,050.00%	-21.05%	53.33%	-291.30%
Operating Cash Flow Q/Q Growth	331.34%	-171.16%	145.45%	-60.29%	1,581.80%	-152.65%	162.69%	-73.58%	739.61%	-24.04%	4.68%
Free Cash Flow Firm Q/Q Growth	44.25%	8.28%	-30.97%	15.46%	113.81%	-292.16%	71.53%	-9.05%	-364.02%	316.11%	-14.47%
Invested Capital Q/Q Growth	-3.66%	12.77%	2.23%	-0.85%	-8.40%	14.53%	-3.59%	2.99%	-5.24%	1.62%	-15.39%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	13.37%	13.15%	12.11%	8.37%	17.63%	15.24%	9.75%	14.81%	13.39%	15.18%	0.65%
EBITDA Margin	5.06%	4.57%	3.21%	-0.20%	7.73%	5.10%	0.26%	4.79%	4.08%	6.03%	-8.96%
Operating Margin	4.05%	3.55%	2.22%	-1.12%	6.72%	4.16%	-0.68%	3.86%	3.15%	5.14%	-10.08%
EBIT Margin	4.05%	3.55%	2.22%	-1.12%	6.72%	4.16%	-0.68%	3.86%	3.15%	5.14%	-10.08%
Profit (Net Income) Margin	3.72%	2.80%	1.97%	-1.23%	5.55%	3.62%	-0.42%	3.28%	2.72%	3.85%	-7.06%
Tax Burden Percent	80.76%	72.24%	75.49%	79.69%	72.78%	71.83%	90.03%	74.60%	80.51%	72.10%	77.27%
Interest Burden Percent	113.83%	109.13%	117.60%	137.82%	113.46%	121.03%	68.70%	113.77%	107.45%	103.86%	90.66%
Effective Tax Rate	19.24%	27.76%	24.51%	0.00%	27.22%	28.17%	0.00%	25.40%	19.49%	27.90%	0.00%
Return on Invested Capital (ROIC)	18.15%	12.32%	7.92%	-3.63%	24.20%	13.06%	-2.10%	12.73%	12.12%	16.66%	-35.65%
ROIC Less NNEP Spread (ROIC-NNEP)	16.69%	11.28%	6.54%	-1.10%	21.40%	9.45%	-2.39%	10.62%	11.43%	16.07%	-35.63%
Return on Net Nonoperating Assets (RNNOA)	-5.03%	-2.39%	-1.32%	0.18%	-4.88%	-1.52%	0.42%	-1.83%	-2.85%	-3.49%	9.28%
Return on Equity (ROE)	13.12%	9.93%	6.59%	-3.45%	19.31%	11.53%	-1.68%	10.90%	9.26%	13.17%	-26.37%
Cash Return on Invested Capital (CROIC)	-3.42%	-1.83%	-5.42%	-1.87%	5.69%	3.42%	6.87%	7.16%	1.89%	14.20%	18.90%
Operating Return on Assets (OROA)	9.13%	8.14%	4.95%	-2.54%	14.85%	9.16%	-1.46%	8.44%	6.78%	10.99%	-22.30%
Return on Assets (ROA)	8.39%	6.42%	4.39%	-2.78%	12.27%	7.96%	-0.91%	7.17%	5.86%	8.23%	-15.62%
Return on Common Equity (ROCE)	13.12%	9.93%	6.59%	-3.45%	19.31%	11.53%	-1.68%	10.90%	9.26%	13.17%	-26.37%
Return on Equity Simple (ROE_SIMPLE)	0.00%	7.85%	7.99%	6.94%	0.00%	8.86%	6.78%	10.45%	0.00%	8.05%	2.27%
Net Operating Profit after Tax (NOPAT)	14	11	7.02	-3.22	21	13	-2.02	12	11	17	-32
NOPAT Margin	3.27%	2.56%	1.68%	-0.78%	4.89%	2.99%	-0.47%	2.88%	2.53%	3.71%	-7.05%
Net Nonoperating Expense Percent (NNEP)	1.46%	1.04%	1.38%	-2.54%	2.80%	3.60%	0.29%	2.11%	0.69%	0.60%	-0.02%
Return On Investment Capital (ROIC_SIMPLE)	3.07%	-	-	-	4.20%	-	-	-	2.18%	3.18%	-6.68%
Cost of Revenue to Revenue	86.63%	86.85%	87.89%	91.63%	82.37%	84.76%	90.25%	85.19%	86.61%	84.82%	99.35%
SG&A Expenses to Revenue	9.32%	9.60%	9.89%	9.49%	10.91%	11.08%	10.42%	10.95%	10.24%	10.04%	10.72%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.32%	9.60%	9.89%	9.49%	10.91%	11.08%	10.42%	10.95%	10.24%	10.04%	10.72%
Earnings before Interest and Taxes (EBIT)	17	15	9.30	-4.60	28	18	-2.89	17	14	23	-46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21	19	13	-0.81	33	22	1.12	21	18	27	-41
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.13	2.34	2.46	1.75	1.68	1.94	1.65	1.68	1.70	1.44	2.30
Price to Tangible Book Value (P/TBV)	2.72	2.95	3.06	2.19	2.08	2.38	2.02	2.03	2.05	1.75	2.82
Price to Revenue (P/Rev)	0.53	0.61	0.66	0.46	0.46	0.55	0.46	0.48	0.50	0.43	0.62
Price to Earnings (P/E)	33.22	36.44	38.34	32.02	19.14	21.88	23.98	14.82	21.83	17.74	91.43
Dividend Yield	7.11%	6.15%	5.71%	8.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.01%	2.74%	2.61%	3.12%	5.23%	4.57%	4.17%	6.75%	4.58%	5.64%	1.09%
Enterprise Value to Invested Capital (EV/IC)	2.43	2.59	2.73	1.88	1.90	2.13	1.81	1.84	1.94	1.60	2.93
Enterprise Value to Revenue (EV/Rev)	0.47	0.57	0.62	0.42	0.39	0.50	0.41	0.43	0.42	0.35	0.53
Enterprise Value to EBITDA (EV/EBITDA)	11.36	14.37	17.27	13.35	10.15	12.58	12.60	9.52	11.84	9.09	38.63
Enterprise Value to EBIT (EV/EBIT)	15.12	19.28	24.10	19.34	13.64	16.59	17.86	12.12	16.07	11.99	132.06
Enterprise Value to NOPAT (EV/NOPAT)	19.67	25.05	31.85	25.42	18.86	22.99	25.29	16.72	21.55	16.09	190.77
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	168.25	252.42	41.85	15.05	24.96	16.15	16.43	23.49	7.17	9.70
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	34.06	64.29	26.33	26.25	106.81	11.01	14.16
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.08	0.10	0.11	0.13	0.08	0.11	0.09	0.07	0.02	0.02	0.01
Long-Term Debt to Equity	0.02	0.02	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.01
Financial Leverage	-0.30	-0.21	-0.20	-0.17	-0.23	-0.16	-0.17	-0.17	-0.25	-0.22	-0.26
Leverage Ratio	1.72	1.65	1.69	1.71	1.73	1.66	1.69	1.67	1.67	1.65	1.69
Compound Leverage Factor	1.96	1.80	1.99	2.35	1.96	2.01	1.16	1.90	1.79	1.71	1.53
Debt to Total Capital	7.33%	9.00%	10.27%	11.37%	7.35%	9.63%	7.94%	6.51%	1.58%	1.52%	1.46%
Short-Term Debt to Total Capital	5.54%	7.23%	7.97%	9.03%	5.07%	7.62%	5.86%	4.78%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	1.79%	1.77%	2.30%	2.34%	2.28%	2.02%	2.08%	1.73%	1.58%	1.52%	1.46%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	92.67%	91.00%	89.73%	88.63%	92.65%	90.37%	92.06%	93.49%	98.42%	98.48%	98.54%
Debt to EBITDA	0.47	0.65	0.86	1.07	0.56	0.76	0.74	0.45	0.13	0.12	0.29
Net Debt to EBITDA	-1.25	-1.02	-1.17	-1.22	-1.73	-1.18	-1.65	-1.26	-2.09	-2.04	-6.46
Long-Term Debt to EBITDA	0.11	0.13	0.19	0.22	0.17	0.16	0.19	0.12	0.13	0.12	0.29
Debt to NOPAT	0.81	1.13	1.58	2.03	1.04	1.38	1.49	0.79	0.24	0.21	1.43
Net Debt to NOPAT	-2.17	-1.78	-2.16	-2.32	-3.20	-2.16	-3.30	-2.22	-3.80	-3.62	-31.90
Long-Term Debt to NOPAT	0.20	0.22	0.35	0.42	0.32	0.29	0.39	0.21	0.24	0.21	1.43
Altman Z-Score	5.00	5.53	5.26	4.58	4.47	4.74	4.41	4.67	4.82	4.61	4.88
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.69	3.15	2.90	2.84	2.64	2.77	2.74	2.93	2.89	2.89	2.49
Quick Ratio	2.42	2.85	2.65	2.60	2.45	2.45	2.41	2.59	2.54	2.52	2.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-37	-34	-45	-38	5.23	-11	-3.10	-3.38	-16	34	29
Operating Cash Flow to CapEx	2,655.80%	-1,709.34%	699.06%	159.78%	3,450.45%	-1,198.02%	1,374.81%	317.99%	2,569.48%	1,601.69%	2,199.16%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.26	2.29	2.23	2.27	2.21	2.20	2.16	2.19	2.15	2.14	2.21
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.08	0.00	0.00
Inventory Turnover	63.45	65.97	67.79	70.40	73.49	75.94	77.69	80.45	84.46	85.42	89.69
Fixed Asset Turnover	66.18	67.09	63.72	62.62	64.60	63.80	59.36	59.11	60.23	59.49	61.05
Accounts Payable Turnover	22.56	23.15	22.33	21.37	19.23	21.17	21.32	19.80	18.10	19.89	21.04
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	71.88	0.00	0.00
Days Inventory Outstanding (DIO)	5.75	5.53	5.38	5.18	4.97	4.81	4.70	4.54	4.32	4.27	4.07
Days Payable Outstanding (DPO)	16.18	15.77	16.35	17.08	18.98	17.24	17.12	18.43	20.17	18.35	17.35
Cash Conversion Cycle (CCC)	-10.43	-10.24	-10.96	-11.90	-14.02	-12.43	-12.42	-13.90	56.04	-14.08	-13.28
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	330	372	380	377	345	396	381	393	372	378	320
Invested Capital Turnover	5.55	4.81	4.73	4.65	4.95	4.37	4.42	4.42	4.78	4.50	5.05
Increase / (Decrease) in Invested Capital	51	45	52	35	15	24	1.08	16	27	-17	-61
Enterprise Value (EV)	801	963	1,037	709	655	843	689	724	724	605	939
Market Capitalization	889	1,032	1,108	774	766	922	779	820	851	741	1,096
Book Value per Share	$5.65	$5.92	$6.07	$5.95	$6.18	$6.42	$6.40	$6.66	$6.82	$7.00	$6.54
Tangible Book Value per Share	$4.41	$4.71	$4.87	$4.76	$5.00	$5.24	$5.23	$5.49	$5.66	$5.77	$5.33
Total Capital	451	484	502	498	493	525	512	523	508	522	484
Total Debt	33	44	52	57	36	51	41	34	8.03	7.95	7.05
Total Long-Term Debt	8.10	8.59	12	12	11	11	11	9.03	8.03	7.95	7.05
Net Debt	-88	-69	-70	-65	-111	-79	-90	-96	-128	-136	-157
Capital Expenditures (CapEx)	0.86	0.95	1.06	1.84	1.43	2.17	1.19	1.36	1.41	1.72	1.31
Debt-free, Cash-free Net Working Capital (DFCFNWC)	223	271	278	269	232	281	263	276	228	232	154
Debt-free Net Working Capital (DFNWC)	345	383	399	391	380	411	394	406	364	376	318
Net Working Capital (NWC)	320	348	359	346	355	371	364	381	364	376	318
Net Nonoperating Expense (NNE)	-1.92	-0.98	-1.24	1.83	-2.79	-2.66	-0.24	-1.70	-0.83	-0.64	0.02
Net Nonoperating Obligations (NNO)	-88	-69	-70	-65	-111	-79	-90	-96	-128	-136	-157
Total Depreciation and Amortization (D&A)	4.30	4.25	4.14	3.79	4.31	3.99	4.02	3.98	4.10	4.00	5.12
Debt-free, Cash-free Net Working Capital to Revenue	13.20%	16.11%	16.57%	16.11%	13.90%	16.78%	15.61%	16.21%	13.31%	13.35%	8.71%
Debt-free Net Working Capital to Revenue	20.39%	22.79%	23.85%	23.37%	22.72%	24.50%	23.37%	23.85%	21.22%	21.62%	17.97%
Net Working Capital to Revenue	18.91%	20.70%	21.46%	20.67%	21.23%	22.12%	21.59%	22.38%	21.22%	21.62%	17.97%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.22	$0.17	$0.12	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.16	$0.23	($0.44)
Adjusted Weighted Average Basic Shares Outstanding	74.34M	74.50M	74.48M	74.36M	74.29M	73.93M	73.85M	73.69M	73.75M	73.67M	73.16M
Adjusted Diluted Earnings per Share	$0.22	$0.17	$0.12	($0.07)	$0.32	$0.21	($0.02)	$0.19	$0.15	$0.23	($0.44)
Adjusted Weighted Average Diluted Shares Outstanding	74.35M	74.52M	74.57M	74.36M	74.34M	74.06M	73.85M	73.93M	73.99M	73.96M	73.16M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	74.39M	74.20M	74.20M	73.85M	73.58M	73.65M	73.38M	73.29M	73.49M	72.92M	72.41M
Normalized Net Operating Profit after Tax (NOPAT)	14	11	7.02	-3.22	21	13	-2.02	12	11	17	-32
Normalized NOPAT Margin	3.27%	2.56%	1.68%	-0.78%	4.89%	2.99%	-0.47%	2.88%	2.53%	3.71%	-7.05%
Pre Tax Income Margin	4.61%	3.87%	2.61%	-1.54%	7.62%	5.03%	-0.47%	4.39%	3.38%	5.34%	-9.14%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	185.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	188.20%	8.95%	8.59%	23.19%	31.66%	24.01%	40.93%	19.75%	15.32%	33.34%	170.86%

Key Financial Trends

Healthcare Services Group (HCSG) delivered a solid Q1 2025, with revenue up 5.7% year-over-year to $447.7 million and net income to common shareholders rising 18% to $17.7 million (EPS $0.23). Operating margins expanded, free cash flow remained robust, and the balance sheet continues to show negative net debt, underpinning strong liquidity and capital efficiency.

Revenue grew 5.7% Y/Y to $447.7 M in Q1 2025, marking the sixth consecutive quarter of year-over-year increases.
Net income to common rose to $17.73 M (+18% Y/Y), translating to EPS of $0.23, up from $0.21 a year ago.
Operating margin widened to 5.14% (vs. 4.16% in Q1 2024), driven by disciplined cost management.
Free cash flow to the firm was $33.9 M, reflecting strong cash generation after CapEx.
Net debt remained negative $136 M, yielding a debt/EBITDA ratio of just 0.12× and bolstering financial flexibility.
Return on invested capital (ROIC) increased to 16.7%, up from 12.1% in Q4 2024, highlighting improved capital efficiency.
Quarter-over-quarter revenue growth was a modest 2.3%, in line with seasonal patterns.
SG&A expenses stayed steady at ~10% of revenue, maintaining consistent operating leverage.
Net cash from operating activities fell to $27.5 M in Q1 2025 from $36.2 M in Q4 2024, reflecting typical working-capital swings.
Valuation multiples remain elevated (P/E ~17.7×, EV/EBITDA ~9.1×), leaving limited margin for error if growth slows.

07/25/25 09:22 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Healthcare Services Group's Financials

When does Healthcare Services Group's financial year end?

According to the most recent income statement we have on file, Healthcare Services Group's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Healthcare Services Group's net income changed over the last 10 years?

Healthcare Services Group's net income appears to be on a downward trend, with a most recent value of $39.47 million in 2024, rising from $21.85 million in 2014. The previous period was $38.39 million in 2023. Check out Healthcare Services Group's forecast to explore projected trends and price targets.

What is Healthcare Services Group's operating income?

Healthcare Services Group's total operating income in 2024 was $45.03 million, based on the following breakdown:

Total Gross Profit: $228.09 million
Total Operating Expenses: $183.06 million

How has Healthcare Services Group's revenue changed over the last 10 years?

Over the last 10 years, Healthcare Services Group's total revenue changed from $1.29 billion in 2014 to $1.72 billion in 2024, a change of 32.7%.

How much debt does Healthcare Services Group have?

Healthcare Services Group's total liabilities were at $302.85 million at the end of 2024, a 9.3% decrease from 2023, and a 56.3% increase since 2014.

How much cash does Healthcare Services Group have?

In the past 10 years, Healthcare Services Group's cash and equivalents has ranged from $9.56 million in 2017 to $139.33 million in 2020, and is currently $56.78 million as of their latest financial filing in 2024.

How has Healthcare Services Group's book value per share changed over the last 10 years?

Over the last 10 years, Healthcare Services Group's book value per share changed from 3.90 in 2014 to 6.82 in 2024, a change of 74.8%.

Related Companies

This page (NASDAQ:HCSG) was last updated on 7/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthcare Services Group (HCSG) Financials

Key Financial Trends

Frequently Asked Questions About Healthcare Services Group's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Healthcare Services Group (HCSG) Financials

Annual Income Statements for Healthcare Services Group

Quarterly Income Statements for Healthcare Services Group

Annual Cash Flow Statements for Healthcare Services Group

Quarterly Cash Flow Statements for Healthcare Services Group

Annual Balance Sheets for Healthcare Services Group

Quarterly Balance Sheets for Healthcare Services Group

Annual Metrics And Ratios for Healthcare Services Group

Quarterly Metrics And Ratios for Healthcare Services Group

Key Financial Trends

Frequently Asked Questions About Healthcare Services Group's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools